For safety and efficacy in targeted abdominal MR Imaging

Achievements

Our background

CMC Contrast AB (Copenhagen Malmö Contrast AB) was established in April 2000 to develop an invention by professor Henrik Thomsen at Copenhagen University Hospital in Herlev, Denmark. It was founded by two main owners: Malmöhus Invest AB and Øresund - Healthcare Capital KS. In December 2007 the venture capital company Sunstone Capital joined as a new investor in CMC Contrast AB.

The pre-clinical as well as the clinical research and development process have been conducted in close cooperation with several international key opinion leaders in the field of contrast media.

About CMC Contrast

100% owned and financed by professional venture capital companies specializing in life sciences and dedicated to contrast agents

Learn more
Medical background

CMC 001 delivers manganese orally, resulting in excellent liver enhancement in MRI.

Medical background
Benefits for your team

Using CMC 001 creates advantages for the staff, and saves time and cost.

More Benefits
CMC Contrast AB, Ideon, SE-223 70 Lund. Telephone +46 46 286 37 60. E-mail: info@cmc-contrast.se